Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse
Open Access
- 31 October 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 30 (9) , 579-585
- https://doi.org/10.1038/sj.bmt.1703659
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease.European Journal of Haematology, 2009
- Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genesLeukemia, 1997
- A highly discriminating octoplex short tandem repeat polymerase chain reaction system suitable for human individual identificationElectrophoresis, 1995
- Forensic application of a rapid and quantitative DNA sex test by amplification of the X-Y homologous gene amelogeninInternational journal of legal medicine, 1994
- The validation of short tandem repeat (STR) loci for use in forensic caseworkInternational journal of legal medicine, 1994
- Immunoglobulin gene ‘fingerprinting’: an approach to analysis of B lymphoid clonality in lymphoproliferative disordersBritish Journal of Haematology, 1991
- Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction.Journal of Clinical Pathology, 1990
- Cytogenetic follow-up after bone marrow transplantation for Philadelphia-positive chronic myeloid leukemiaCancer Genetics and Cytogenetics, 1989
- Avoiding false positives with PCRNature, 1989